Keywords: ASD, <1 month, Biomarkers of Atypical Development
What is being studied?
The purpose of this study is to 1) improve early screening for autism so that infants can be steered towards early intervention, 2) identify reliable biological markers of autism, and 3) explain the brain mechanisms underlying delays or differences in early development. We will use electrophysiology (EEG) and magnetic resonance imaging (MRI) to study brain development and function, and we will use behavioral testing and parent questionnaires to examine early social and cognitive skills. Additionally, we want to learn more about how genes affect the development of autism, so we are also gathering genetic material, or DNA, from infants in this study to understand the role of genetic factors in different brain patterns. We will evaluate the link between genes, brain imaging and the earliest behavioral signs of autism to identify early markers of autism and to understand why developmental outcomes might differ across high risk infants.
Who can participate?
We are actively recruiting families with an infant less than six weeks of age. Infants must meet one of the following criteria:
is the sibling of a child diagnosed with autism
has a clinically confirmed diagnosis of Tuberous Sclerosis Complex
has a clinically confirmed diagnosis of 22q11.2 deletion or duplication syndrome
is an infant with no family history of autism.
Whom should I contact to get involved?
If you are interested in participating in this study, please contact Lisa Jackson at (310) 825-3478 or